Merja Soilu-Hänninen
MD, PhD
Turku University Hospital, Division of Clinical Neurosciences mersoi@utu.fi ORCID identifier: https://orcid.org/0000-0001-6930-0229 |
Clinical neurology; neuroimmunology; multiple sclerosis risk factors, prognostic factors and treatment
MD, University of Turku 1988
PhD, University of Turku, Department of Virology, Immunobiology of central nervous system virus infections 1996
Postdoctoral Fellow, Development and Neurobiology Group, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia 1997-1999
Specialist Degree in Neurology 2001
Adjuct Professor of Clinical Neurology 2008
Inverstigator in several clinical MS trials
Chair of the Finnish MS registry 2016-
General Neurology Section Head, Turku University Hospital, Division of Clinical Neurosciences 2017-
Multiple sclerosis risk factors, prognostic factors and epidemiology.
Imaging of brain atrophy in multiple sclerosis.
Course of medical pedagogics 2011-2012
Supervisor of several PhD student
- Medication adherence/persistence among patients with active multiple sclerosis in Finland (2020)
- Acta Neurologica Scandinavica
(A1 Refereed original research article in a scientific journal) - Thalamic Atrophy Predicts 5-Year Disability Progression in Multiple Sclerosis (2020)
- Frontiers in Neurology
(A1 Refereed original research article in a scientific journal) - Trends and characteristics of infection-related hospital admissions in multiple sclerosis patients in Southwest Finland in 2009–2018 (2020)
- Multiple Sclerosis and Related Disorders
(A1 Refereed original research article in a scientific journal) - Vitamin D supplementation and serum neurofilament light chain in interferon-beta-1b-treated MS patients (2020)
- Brain and Behavior
(A1 Refereed original research article in a scientific journal) - Epstein–barr virus and multiple sclerosis risk in the finnish maternity cohort (2019)
- Annals of Neurology
(A1 Refereed original research article in a scientific journal) - Hospital admission and prevalence trends of adult myasthenia gravis in Finland in 2004–2014: A retrospective national registry study (2019)
- Journal of the Neurological Sciences
(A1 Refereed original research article in a scientific journal) - MS-tauti ja kognitiivinen toimintakyky (2019)
- Duodecim
(A2 Refereed review article in a scientific journal ) - Multiple sclerosis epidemiology in Finland: regional differences and high incidence (2019)
- Acta Neurologica Scandinavica
(A1 Refereed original research article in a scientific journal) - Multiple sclerosis in Finland 2018—Data from the national register (2019)
- Acta Neurologica Scandinavica
(A1 Refereed original research article in a scientific journal) - Multiple sclerosis registries in Europe - An updated mapping survey (2019)
- Multiple Sclerosis and Related Disorders
(B1 Non-refereed article in a scientific journal) - Progressive dopaminergic defect in a patient with primary progressive multiple sclerosis (2019)
- Multiple Sclerosis and Related Disorders
(B1 Non-refereed article in a scientific journal) - Progressive multifocal leukoencephalopathy in Finland: a cross-sectional registry study (2019)
- Journal of Neurology
(A1 Refereed original research article in a scientific journal) - Risk of cancer among Finnish multiple sclerosis patients (2019)
- Multiple Sclerosis and Related Disorders
(A1 Refereed original research article in a scientific journal) - Thalamic Atrophy Without Whole Brain Atrophy Is Associated With Absence of 2-Year NEDA in Multiple Sclerosis (2019)
- Frontiers in Neurology
(A1 Refereed original research article in a scientific journal) - Adult hospital admissions associated with multiple sclerosis in Finland in 2004-2014 (2018)
- Annals of Medicine
(A1 Refereed original research article in a scientific journal) - Common comorbidities and survival in MS: Risk for stroke, type 1 diabetes and infections (2018)
- Multiple Sclerosis and Related Disorders
(A1 Refereed original research article in a scientific journal) - Efficacy and safety outcomes in vitamin D supplement users in the fingolimod phase 3 trials (2018)
- Journal of Neurology
(A1 Refereed original research article in a scientific journal) - Hemophagocytic lymphohistiocytosis in 2 patients with multiple sclerosis treated with alemtuzumab (2018)
- Neurology
(A1 Refereed original research article in a scientific journal) - Monoklonaaliset vasta-aineet MS-taudin hoidossa (2018)
- Duodecim
(A2 Refereed review article in a scientific journal ) - 25-Hydroxyvitamin D deficiency and risk of MS among women in the Finnish Maternity Cohort (2017)
- Neurology
(A1 Refereed original research article in a scientific journal)